Showing 5201-5210 of 19420 results for "".
A New Era in Primary Biliary Cholangitis Treatment
https://reachmd.com/programs/gi-insights/a-new-era-in-primary-biliary-cholangitis-treatment/49146/Primary biliary cholangitis (PBC) treatment has evolved significantly in recent years, expanding beyond ursodiol to include new targeted therapies and emerging agents in clinical trials. As the therapeutic landscape grows, clinicians are also refining how they assess treatment response using biochemThe Complexities of DMD: Optimizing Multidisciplinary Care
https://reachmd.com/programs/neurofrontiers/the-complexities-of-dmd-optimizing-multidisciplinary-care/32358/As patients with Duchenne muscular dystrophy (DMD) transition into adulthood, their care becomes increasingly multifaceted. Explore how multidisciplinary teams can help address evolving needs in this population with Dr. Rosaline Quinlivan, Professor of Neuromuscular Disease at University College LonPsoriasis Risks and Variants: Educating Patients to Optimize Outcomes
https://reachmd.com/programs/dermconsult/psoriasis-risks-and-variants-educating-patients-to-optimize-outcomes/32454/Education is an important part of effective psoriasis management. Learn how to talk to patients about its risks and variants to enhance outcomes.Peanut Butter Smell Test 'Sniffs Out' Alzheimer’s Disease
https://reachmd.com/programs/curious-headlines-dispatches-from-the-stranger-side-of-medicine/peanut-butter-smell-test-sniffs-out-alzheimers-disease/7721/Research published in the Journal of Neurological Sciences is touting a “peanut butter smell test” which proposes to help detect early Alzheimer’s Disease. It’s based on a study which found that patients with early stage Alzheimer’s exhibited a significant impairment in their sense of smell, specifiThe Future of MS Management: Novel Agents and Clinical Approaches
https://reachmd.com/programs/neurofrontiers/program-name/36360/The multiple sclerosis (MS) treatment landscape is rapidly evolving, with novel approaches on the horizon that may transform care for progressive patients. Explore the latest phase 3 data on BTK inhibitors like tolebrutinib and gain insights into ongoing CAR T-cell and remyelination research, includDrug-Free Brain Health: Treatments Using Virtual Reality and Video Games
https://reachmd.com/programs/conversations-on-health-care/drug-free-brain-health-treatments-using-virtual-reality-and-video-games/8495/Dr. Adam Gazzaley discusses his closed loop system designed to improve brain function through personalized game design and feedback.Managing the Side Effects of ADHD Medications
https://reachmd.com/programs/updates-from-mayo-clinic/managing-the-side-effects-of-adhd-medications/6786/Host Dr. Peter Jensen welcomes Dr. Martin Stein, Professor of Pediatrics at the University of California, San Diego, and Rady Children's Hospital, San Diego. Dr. Stein's academic interest has been the development of methods to incorporate concepts about child development and behavioral pediatrics inOptimizing HCC Screening: Strategies to Overcome Common Barriers
https://reachmd.com/programs/project-oncology/optimizing-hcc-screening-strategies-to-overcome-common-barriers/26253/Tune in to hear expert insights on common barriers to hepatocellular carcinoma screening and how we can overcome them.Emerging Use of Ketamine for the Treatment of Migraine and Other Headache Disorders
https://reachmd.com/programs/practical-neurology/emerging-use-of-ketamine-for-the-treatment-of-migraine-and-other-headache-disorders/35431/Peter McAllister, MD, FAAN, Chief Medical Officer of the New England Institute for Neurology and Headache, Stamford, CT, discusses the application of ketamine in neurologic practice for the treatment of migraine and other headache disorders, including experiences from his clinical practice.DWTV Extra: DermLink Scholars Founder Dr. Kelly Frasier
https://reachmd.com/series/dermwire-tv/DWTV-Extra-DermLink-Scholars-Founder-Dr-Kelly-Frasier/36554/DermLink Scholars Founder and CEO Kelly Frasier, DO, MS, CRC, and Alina G. Bridges, DO, FAAD, discuss the organization and its inaugural virtual conference Saturday, August 2. For more information, go to dermlinkscholars.com.